Skip to content

2seventy bio, Inc.

CIK 0001860782

← back to feed
Revenue (TTM)
$57.87M
−62.3% YoY Q1 May 2025
Net Income (TTM)
−$37.25M
+73.7% YoY Q1 May 2025
EPS Diluted (TTM)
−$0.74
+75.1% YoY Q1 May 2025
Gross Margin
99.0%
Q1 May 2025
Operating Margin
-163.6%
Q1 May 2025
Net Margin
-64.4%
Q1 May 2025
Free Cash Flow (TTM)
−$185.7M
Q1 May 2025
Cash
$92.36M
Q1 May 2025
Total Debt
—
Q1 May 2025
Shares Outstanding
53.23M sh
Q1 May 2025

Revenue & Net Income

EPS (Diluted)

Margins

Cash Flow

Revenue Growth (YoY)

Balance Sheet

Cash vs Debt

Recent filings